Effects of a myristoylated pseudosubstrate inhibitor of PKC in intact human platelets.
Wheeler-Jones
C P
CP
Vascular Biology Research Centre, King's College London.
Sayed
S
S
Persaud
S J
SJ
D001792:Blood Platelets / Q000201:enzymology*; D006801:Humans; D007700:Kinetics; D019814:Myristic Acid; D009227:Myristic Acids / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000097:blood*; D013379:Substrate Specificity; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D009227:Myristic Acids; D009842:Oligopeptides; D010446:Peptide Fragments; D019814:Myristic Acid; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate